Related Experiment Video
Updated: Oct 21, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Clinical Subphenotypes in Critically Ill Patients With COVID-19: Now Looking for Different Treatment Responses!
1Université Paris-Saclay, AP-HP, Service de médecine intensive-réanimation, hôpital de Bicêtre, DMU 4 CORREVE Maladies du cœur et des vaisseaux, Le Kremlin-Bicêtre, France; Équipe d'Épidémiologie Respiratoire Intégrative, Center for Epidemiology and Population Health (CESP), Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm U1018, Villejuif, France; Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, Créteil, France.
No abstract available in PubMed .
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Psychosis: Goals of Pharmacotherapy
Acute Coronary Syndrome IV: Interprofessional Care
Acute Respiratory Failure-IV
Acute Coronary Syndrome V: Nursing Management

